Welcome to our dedicated page for Umeworld SEC filings (Ticker: UMEWF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The UMeWorld Limited (UMEWF) SEC filings page provides access to regulatory documents filed by UMeWorld Inc., the Delaware corporation through which the company conducts its operations. These filings give investors insight into the company’s functional nutrition, wellness technology, and enzymatic biofuel activities, as well as its corporate structure and governance.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, typically describe UMeWorld’s DAGola functional cooking oil business, clinical validation of diacylglycerol (DAG) oils, development of sports nutrition and AI-powered wellness offerings, and progress on its enzymatic biofuel and Sustainable Aviation Fuel (SAF) platform. These reports also discuss risk factors, accounting policies, and other disclosures relevant to the company’s operations and markets.
Current reports on Form 8-K highlight material events. For example, an 8-K dated January 5, 2026, details a change in UMeWorld Inc.’s independent registered public accounting firm due to required audit engagement partner rotation, noting that there were no disagreements on accounting principles, financial statement disclosure, or auditing scope or procedure for the referenced periods. Similar 8-K filings can cover items such as mergers, governance changes, or significant financing transactions.
Investors can also review proxy statements and related materials, when filed, for information on board composition, executive compensation, and shareholder matters, as well as registration statements associated with capital-raising or corporate reorganizations. If UMeWorld insiders report transactions in company securities, Form 4 filings provide details on those trades.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections, and surface important changes over time. This helps readers interpret complex disclosures on topics such as enzymatic technology, waste-based feedstock strategies, and wellness product development without manually reviewing every page. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 submissions for UMEWF are reflected promptly, supporting more efficient research and monitoring.
UMeWorld Inc. director Milroy John David filed an initial statement of ownership on Form 3. He reports direct beneficial ownership of 1,342,131 shares of common stock and indirect beneficial ownership of 38,000 shares held by his spouse, all as of January 21, 2026.
UMeWorld Inc. reported a sharp jump in quarterly revenue but remains deeply unprofitable and financially strained. For the three months ended December 31, 2025, revenue rose to
The company still posted a net loss of
Inventory ballooned to
UMeWorld Inc. Chairman and CEO Lee Man Ching has filed an initial insider ownership report, disclosing direct holdings of 7,242,291 shares of UMeWorld common stock. This Form 3 filing records his existing ownership position and, based on the data shown, does not reflect new buying or selling activity.
UMeWorld Inc. filed a notice that it will not submit its Quarterly Report on Form 10‑Q for the quarter ended December 31, 2025 on time. The delay stems from the resignation of its former independent auditor on December 31, 2025 due to that firm’s internal partner‑rotation policy and related PCAOB compliance concerns, and the company has not yet engaged a successor firm to review the interim financial statements.
The company also recently redomiciled from the British Virgin Islands to Delaware, with a related name change and shift to U.S. domestic issuer reporting, which has strained internal accounting and administrative resources. UMeWorld expects to file the 10‑Q within the five‑calendar‑day extension allowed under Rule 12b‑25. For the quarter, it anticipates a significant increase in total revenue versus the prior‑year period, driven by commercial scaling of its DAGola™ functional nutrition platform and international expansion, but it cannot yet reasonably estimate net income, earnings per share, or other specific financial results.
UMeWorld Inc. reported that, effective January 21, 2026, FINRA completed its corporate action for the company. The common stock now trades on the OTC Markets under the new symbol "UMEW" with a new CUSIP number 90292A105, and the prior CUSIP has been suspended for market purposes.
The company also completed its redomiciliation from the British Virgin Islands to the State of Delaware and formally changed its corporate name from UMeWorld Limited to UMeWorld Inc. These steps follow a previously completed share exchange and domestication process and reflect FINRA’s successor-issuer recognition. A press release announcing the effectiveness of this corporate action was issued on January 21, 2026.
UMeWorld Inc. reported that its independent registered public accounting firm, J&S Associate PLT, resigned effective December 31, 2025. The firm stepped down due to required audit engagement partner rotation under PCAOB independence rules and Regulation S‑X, rather than any issue with the company.
The auditor’s reports on UMeWorld’s financial statements for the years ended September 30, 2024 and September 30, 2025 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements or reportable events with the auditor during these periods. UMeWorld has asked the former auditor to provide a confirming letter to the SEC, which is included as Exhibit 16.1.
UMeWorld Inc. (UMEWF) reports very early-stage operations with persistent losses and going‑concern risk. For the year ended September 30, 2025, revenue was only
Total assets were
The company completed a redomiciliation from the British Virgin Islands to Delaware on October 2, 2025 and now operates primarily through Dagola Inc. in Miami, selling DAGola® oils, while its biofuel initiative, Project Verdant, remains at an early, non‑revenue planning stage. UMeWorld has identified material weaknesses in internal control, is traded as a penny stock on the OTC market, has only one full‑time employee, and relies heavily on a few major shareholders and related‑party financing.